ciprofloxacin has been researched along with Lung Injury, Acute in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"aeruginosa-induced NET formation and lung inflammation." | 1.72 | CLEC5A is critical in Pseudomonas aeruginosa-induced NET formation and acute lung injury. ( Chiu, CH; Hsieh, SL; Peng, YC; Sung, PS; Yang, SP, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sung, PS | 1 |
Peng, YC | 1 |
Yang, SP | 1 |
Chiu, CH | 1 |
Hsieh, SL | 1 |
Wilson, CN | 1 |
Vance, CO | 1 |
Doyle, TM | 1 |
Brink, DS | 1 |
Matuschak, GM | 1 |
Lechner, AJ | 1 |
2 other studies available for ciprofloxacin and Lung Injury, Acute
Article | Year |
---|---|
CLEC5A is critical in Pseudomonas aeruginosa-induced NET formation and acute lung injury.
Topics: Acute Lung Injury; Animals; Caspases; Ciprofloxacin; Cytokines; Lectins, C-Type; Lipopolysaccharides | 2022 |
A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis.
Topics: Acute Lung Injury; Animals; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Humans | 2012 |